Adolescent and young adult non-Hodgkin lymphoma

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

(2015) C. Copie-Bergman et al.   BLOOD

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas

(2015) E. Braggio et al.   CLINICAL CANCER RESEARCH

The molecular pathogenesis of B-cell non-Hodgkin lymphoma

(2015) Piers A. Blombery et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

International Pediatric Non-Hodgkin Lymphoma Response Criteria

(2015) John T. Sandlund et al.   JOURNAL OF CLINICAL ONCOLOGY

Revised International Pediatric Non-Hodgkin Lymphoma Staging System

(2015) Angelo Rosolen et al.   JOURNAL OF CLINICAL ONCOLOGY

Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study

(2015) Angela Matinella et al.   JOURNAL OF NEUROLOGY

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

(2014) D. Hoelzer et al.   BLOOD

Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Munster protocols for systemic lymphoma

(2014) H. Thorer et al.   HAEMATOLOGICA

Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients

(2014) Carlo Gambacorti Passerini et al.   JNCI-Journal of the National Cancer Institute

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma

(2014) C. Houillier et al.   NEUROLOGY

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma

(2014) M. Holdhoff et al.   NEUROLOGY

Advanced stage anaplastic large cell lymphoma in children and adolescents: Results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A report from the children's oncology group

(2014) Sarah Alexander et al.   PEDIATRIC BLOOD & CANCER

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma

(2013) C. Damm-Welk et al.   BLOOD

II. Therapy of DLBCL based on genomics

(2013) Louis M. Staudt   HEMATOLOGICAL ONCOLOGY

Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study

(2013) Franck Andre Morschhauser et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

(2013) David Cunningham et al.   LANCET

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

(2013) Yael P Mossé et al.   LANCET ONCOLOGY

Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma

(2013) Kieron Dunleavy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

(2012) Y. H. Messinger et al.   BLOOD

Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy

(2012) M. Gerrard et al.   BLOOD

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

(2012) K. E. Deffenbacher et al.   BLOOD

Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia

(2012) Rodney R. Miles et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial

(2012) Seok Jin Kim et al.   EUROPEAN JOURNAL OF CANCER

Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials

(2012) David Sibon et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Impact ofNOTCH1and/orFBXW7Mutations,FLASHDeletion, andTCRStatus in Pediatric T-Cell Lymphoblastic Lymphoma

(2012) Celine Callens et al.   JOURNAL OF CLINICAL ONCOLOGY

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

(2012) Mitchell S. Cairo et al.   JOURNAL OF CLINICAL ONCOLOGY

Successful Treatment of Primary Central Nervous System Lymphoma without Irradiation in Children: Single Center Experience

(2012) Jong Hyung Yoon et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

(2012) Norbert Schmitz et al.   LANCET ONCOLOGY

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis

(2012) L Mussolin et al.   LEUKEMIA

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

(2012) Jinghui Zhang et al.   NATURE

How I treat primary CNS lymphoma

(2011) A. J. M. Ferreri   BLOOD

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

(2011) E. Campo et al.   BLOOD

Primary CNS Lymphoma in Children and Adolescents: A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG)

(2011) O. Abla et al.   CLINICAL CANCER RESEARCH

Relapsed or Refractory Anaplastic Large-Cell Lymphoma in Children and Adolescents After Berlin-Frankfurt-Muenster (BFM)–Type First-Line Therapy: A BFM-Group Study

(2011) Willi Woessmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study

(2011) Laurence Lamant et al.   JOURNAL OF CLINICAL ONCOLOGY

Prophylactic intrathecal chemotherapy in primary CNS lymphoma

(2011) Monica Sierra del Rio et al.   JOURNAL OF NEURO-ONCOLOGY

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

(2011) Christian Récher et al.   LANCET

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

(2011) Michael Pfreundschuh et al.   LANCET ONCOLOGY

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

(2010) N. Schmitz et al.   BLOOD

Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial

(2010) Marie-Cécile Le Deley et al.   JOURNAL OF CLINICAL ONCOLOGY

Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

(2010) Jia Ruan et al.   JOURNAL OF CLINICAL ONCOLOGY

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

(2010) Eckhard Thiel et al.   LANCET ONCOLOGY

Nodal Diffuse Large B-cell Lymphomas in Children and Adolescents: Immunohistochemical Expression Patterns and c-MYC Translocation in Relation to Clinical Outcome

(2009) Gabriela Gualco et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

(2009) K. Dunleavy et al.   BLOOD

Lessons from clinical trials in African Burkitt lymphoma

(2009) Ian Magrath   CURRENT OPINION IN ONCOLOGY

Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience

(2009) Lilyana Angelov et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group

(2009) Laurence Brugières et al.   JOURNAL OF CLINICAL ONCOLOGY

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

(2009) Elaine Coustan-Smith et al.   LANCET ONCOLOGY

Classification of lymphoid neoplasms: the microscope as a tool for disease discovery

(2008) E. S. Jaffe et al.   BLOOD

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

(2008) K. J. Savage et al.   BLOOD

Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials

(2008) W. Klapper et al.   BLOOD

Recent advances in the understanding and management of diffuse large B-cell lymphoma in children

(2008) Alfred Reiter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science

(2008) Jessica Hochberg et al.   BRITISH JOURNAL OF HAEMATOLOGY

T Cell Receptor Genotyping and HOXA/TLX1 Expression Define Three T Lymphoblastic Lymphoma Subsets which Might Affect Clinical Outcome

(2008) F. Baleydier et al.   CLINICAL CANCER RESEARCH

Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

(2008) Carole Soussain et al.   JOURNAL OF CLINICAL ONCOLOGY

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study

(2008) H A Poirel et al.   LEUKEMIA

Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group

(2008) Rodney R. Miles et al.   PEDIATRIC BLOOD & CANCER

Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941

(2008) Eric J. Lowe et al.   PEDIATRIC BLOOD & CANCER